Right now, doctors at Seattle Cancer Care Alliance (SCCA) are working to unlock the potential that immunotherapy holds for cancer patients, one amazing discovery at a time. Many of the world’s leading immunotherapy researchers are based here at SCCA and our founding institutions, Fred Hutchinson Cancer Research Center, Seattle Children’s, and UW Medicine.
We also house extraordinary resources specific to immunotherapy. These include dedicated facilities for cell processing and clinical-grade vector manufacturing. Having in-house facilities that incorporate best practices from both research and industry is unique among cancer centers. It gives our physician-scientists a tremendous advantage, and it helps patients in our clinical trials get the very best care.
But beyond this, as an SCCA patient, you enter a community of caregivers and researchers who are dedicated to helping you and your family navigate the treatment complexities that cancer poses. An SCCA medical oncologist who specializes in your type of cancer will coordinate every aspect of your treatment. Together, you’ll create a short- and long-term treatment plan. And your cancer care team will make it easy for you to access all of the resources you need.
If your plan includes immunotherapy clinical trials, your oncologist will know what’s available and help you choose the treatment that has the most potential for you. Communication between your oncologist and the doctor leading the clinical trial happens in an efficient and timely way. Our goal is to make sure you always know exactly where your treatment is going.
We are an institution that thrives on bringing medical advances to patients. Our doctors not only know the latest clinical studies that may make a difference in combating your cancer, they are in many instances lead investigators in these studies. As Renato G. Martins, MD, MPH, put it recently, “At SCCA, therapies that will become tomorrow’s standard of care are available today as clinical trials.”